Red blood cell (RBC) autoantibodies are a relatively uncommon cause of anemia. Nevertheless, autoimmune hemolytic anemia (AIHA) should consider in the differential diagnosis of hemolytic anemia whenever patient has an accompanying lymphoproliferative disorder, autoimmune disease, viral or mycoplasma infection. AIHA is further categorized as warm AIHA, cold agglutinin syndrome, paroxysmal cold hemoglobinuria, mixed-type and drug-induced AIHA. It is the characteristic of the autoantibodies which are accountable for various clinical entities. Diagnosis is based on clinical presentation and work up of AIHA. This review discusses epidemiology, causes, clinical presentation, and laboratory workup and treatment options available for AIHA.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.